Large-scale testing (Phase 3)Study completedNCT01610791
What this trial is testing
RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 121